Search Results - "Chagpar, AB"

Abstract P3-10-01: Investigation of HBOC germline mutations in women diagnosed with breast cancer in Trinidad and Tobago by Parkinson, GT, Chagpar, AB, Hofstatter, EW, Nunez-Smith, M

“…Abstract Background: Trinidad and Tobago (T&T) is a southern Caribbean island with a population of approx. 1.3 million. According to WHO/PAHO, T&T has the 2nd…”
Get full text

Abstract P5-13-04: What’s your excuse?: Reasons women with a first degree family history of breast cancer don’t get mammograms by Hibler, L, Hofstatter, EW, Chagpar, AB

“…Abstract Background: Despite national guidelines for routine screening mammography at least every two years beginning at age 40 for all women, and common…”
Get full text

Abstract P1-09-01: African American women have lower pathologic complete response rates to neoadjuvant chemotherapy compared to white women for triple negative and HER 2 positive breast cancer by Killelea, BK, Chagpar, AB, Horowitz, NR, Pusztai, L, Wang, S, Mougalian, S, Lannin, DR

“…Abstract Introduction Although racial disparities in breast cancer treatment have been well documented, data regarding differences in response to neoadjuvant…”
Get full text

Abstract P2-04-02: Comparison of DNA methylation patterns in normal breast tissue from women with and without breast cancer by Hofstatter, EW, Zhu, Y, Horvath, S, Chagpar, AB, Wali, VB, Bossuyt, V, Storniolo, AM, Hatzis, C, Patwardhan, G, Von Wahlde, M-K, Butler, M, Epstein, L, Stavris, K, Sturrock, T, Au, A, Kwei, S, Pusztai, L

“…Abstract BACKGROUND: Increasing evidence suggests that epigenetic mechanisms play critical roles in the development of breast cancer. However, precise DNA…”
Get full text

Abstract PD8-07: Does resection of cavity shave margins result in lower positive margin and re-excision rates in patients with stage 0-III breast cancer? Results from a prospective multicenter randomized controlled trial by Chagpar, AB, Tsangaris, T, Garcia-Cantu, C, Howard-McNatt, M, Chiba, A, Berger, AC, Levine, E, Gass, JS, Gallagher, K, Lum, SS, Martinez, RD, Willis, AI, Pandya, SV, Brown, EA, Fenton, A, Mendiola, A, Murray, M, Haddad, V, Solomon, NL, Senthil, M, Bansil, H, Ollila, D, Snyder, SK, Edmonson, D, Lazar, M, Namm, JP, Li, F, Butler, M, McGowan, NE, Herrera, ME, Avitan, YP, Yoder, B, Dupont, E

“…Abstract INTRODUCTION: Routine resection of cavity shave margins has been shown in single center studies to result in a significant reduction in positive…”
Get full text

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy by CHAGPAR, Anees B, MIDDLETON, Lavinia P, KUERER, Henry M, MERIC-BERNSTAM, Funda, ROSS, Merrick I, SINGLETARY, S. Eva, SAHIN, Aysegul A, DEMPSEY, Peter, BUZDAR, Aman U, MIRZA, Attiqa N, AMES, Fredrick C, BABIERA, Gildy V, FEIG, Barry W, HUNT, Kelly K

“…To assess the accuracy of physical examination, ultrasonography, and mammography in predicting residual size of breast tumors following neoadjuvant…”
Get full text

Abstract PD04-04: What is influencing breast conservation rates in the United States? Data from the National Accreditation Program of Breast Centers by Chagpar, AB, Kaufman, CS, Connolly, J, Burgin, C, Granville, T, Winchester, D

“…Abstract INTRODUCTION: Breast conservation (BC) rates have been utilized as a quality metric, yet mastectomy rates have been noted to be increasing nationwide…”
Get full text

Abstract P3-14-06: The Utility of Margin Index to Predict Residual DCIS Following Breast Conserving Surgery by Aneja, S, Lannin, DR, Killelea, B, Horowitz, NR, Chagpar, AB

“…Abstract Background: Although breast conserving surgery (BCS) is commonly performed for ductal carcinoma in situ (DCIS), patients may require re-excision for…”
Get full text

Gender-related differences in outcome for melanoma patients by Scoggins, Charles R, Ross, Merrick I, Reintgen, Douglas S, Noyes, R Dirk, Goydos, James S, Beitsch, Peter D, Urist, Marshall M, Ariyan, Stephan, Sussman, Jeffrey J, Edwards, Michael J, Chagpar, Anees B, Martin, Robert C G, Stromberg, Arnold J, Hagendoorn, Lee, McMasters, Kelly M

“…To better understand the factors associated with the well-established gender difference in survival for patients with melanoma. Gender is an important factor…”
Get full text

Abstract P3-14-05: Recurrence in Patients Diagnosed with Ductal Carcinoma in Situ: Predictors and Prognostic Significance by Sue, GR, Killelea, B, Horowitz, NR, Lannin, DR, Chagpar, AB

“…Abstract Background: While patients diagnosed with ductal carcinoma in situ (DCIS) enjoy a favorable prognosis, recurrence after definitive management does…”
Get full text

Abstract P3-14-02: Patterns of the use of primary systemic therapy in the United States by Mougalian, SS, Abu-Khalaf, MM, Sanft, T, Hofstatter, E, DiGiovanna, M, Chung, G, Lannin, D, Killelea, B, Pusztai, L, Chagpar, AB

“…Abstract Background: Primary systemic therapy (PST) is an accepted alternative to adjuvant systemic therapy of breast cancer. It provides equivalent survival,…”
Get full text

Abstract P3-13-01: Impact of routine cavity shave margins on time and money: Results from the SHAVE trial by Chagpar, AB, Longley, PB, Horowitz, NR, Killelea, BK, Tsangaris, TN, Li, F, Butler, M, Stavris, K, Yao, X, Harigopal, M, Bossuyt, V, Lannin, DR, Pusztai, L, Loftus, M, Davidoff, AJ, Gross, CP

“…Abstract INTRODUCTION: Taking routine cavity shave margins (CSM) reduces positive margin and re-excision rates by 50%, but the impact of this technique on…”
Get full text

P3-05-08: Hormone Receptor Heterogeneity in Ductal Intraepithelial Neoplasia (Ductal Carcinoma In Situ) of the Breast by Sowden, M, Flynn, C, Bossuyt, V, Lannin, D, Chagpar, AB

“…Abstract Background: Ductal Intraepithelial Neoplasia [DIN] often shows heterogeneity of both morphology and nuclear grade within the same patient. It is…”
Get full text

P3-07-26: How Generalizable Is the Patient Population Enrolled in ACOSOG Z11? by Lannin, DR, Killelea, BK, Grube, BJ, Horowitz, N, Chagpar, AB

“…Abstract Background: The recently published Z11 trial of observation vs. axillary dissection for patients with a positive sentinel lymph node showed amazingly…”
Get full text

Abstract P3-10-10: Progesterone Receptor-Negative Status Predicts Poorer Outcomes in Estrogen Receptor-Positive Patients Treated with Selective Estrogen Receptor Modulators by Chagpar, AB, McMasters, KM, Edwards, MJ

“…Abstract Introduction: While estrogen receptor (ER) status has been used as the primary factor influencing the use of selective estrogen receptor modulators…”
Get full text

Factors associated with surgical options for breast carcinoma by Chagpar, Anees B., Studts, Jamie L., Scoggins, Charles R., Martin, Robert C.G., Carlson, David J., Laidley, Alison L., El‐Eid, Souzan E., McGlothin, Terre Q., Noyes, Robert D., McMasters, Kelly M.

“…BACKGROUND Breast conservation surgery (BCS) and mastectomy have equivalent survival outcomes for women with breast carcinoma, but treatment decisions are…”
Get full text

Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique by Chagpar, Anees B., Martin, Robert C.G., Hagendoorn, Lee J., Chao, Celia, McMasters, Kelly M.

“…The effect of the type of biopsy (needle vs. excisional) on lumpectomy margin status has not been well established. The objective of this study was to…”
Get full text

Skin-sparing and nipple-sparing mastectomy: preoperative, intraoperative, and postoperative considerations by Chagpar, Anees B

“…The last several decades have witnessed significant advances in the surgical management of breast cancer. Although many have embraced breast conservation as…”
Get more information

Abstract P2-12-01: Is Cancer-Specific Distress Correlated with Time to Definitive Surgery in Breast Cancer Patients? by Daup, MB, Lush, EL, Dedert, E, McMasters, KM, Sephton, SE, Chagpar, AB

“…Abstract INTRODUCTION: A number of studies have investigated factors influencing delay in seeking medical care for self-detected breast symptoms. Few, however,…”
Get full text

Factors influencing the decision to add chemotherapy to adjuvant hormonal therapy in women with hormone receptor-positive breast cancer by Chagpar, AB, Lewis, JL, McMasters, KM, Edwards, MJ

“…Abstract Abstract #4105 Introduction: The decision to treat women with hormone receptor-positive breast cancer with chemotherapy in addition to hormonal…”
Get full text